Epigenetics

AU-15330 View larger

AU-15330

AT39954

CAS 2380274-50-8

More details

Molarity Calculation Cart®

HOW TO ORDER

$118.00

$118.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $53.10 Total: $5,310.00
150 $61.36 Total: $3,068.00
125 $71.98 Total: $1,799.50
110 $84.96 Total: $849.60
15 $100.30 Total: $501.50

Data sheet

Molecular FormulaC39H49N9O5S
Molecular Weight755.93
CAS Numbers2380274-50-8
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeC[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CN1CCN(CC1)c1cc(nnc1N)-c1ccccc1O)C(C)(C)C)c1ccc(cc1)-c1scnc1C
ReferencesXiao L, et al. Targeting SWISNF ATPases in enhancer-addicted prostate cancer. Nature. 2022;601[7893] 434-439.

More info

AU-15330 is a protein hydrolysis-targeted chimeric (PROTAC) degrader of the SWISNF ATPase subunits SMARCA2 and SMARCA4.AU-15330 potently inhibits tumor growth in a prostate cancer xenograft model and acts synergistically with the AR antagonist enzalutamide.AU-15330 shows partial therapeutic efficacy and non-toxicity with the AR antagonist enzalutamide in a desmoplasia-resistant prostate cancer (CRPC) model. AU-15330 showed partial therapeutic efficacy in a denervation-resistant prostate cancer (CRPC) model and AU-15330 was characterized by non-toxicity.